F. Calabresi

发表

Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials Group.

M. Piccart, J. Wanders, J. Verweij, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide.

S. Di Cosimo, A. Fabi, P. Carlini, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment.

R Masciulli, F Calabresi, U. Testa, 1990, Cancer research.

IL-2 induces the release of secondary cytokines which stimulate the cytotoxic activity of either NK or CD8+ lymphocytes

C. Peschle, U. Testa, E. Tritarelli, 1991, Cytotechnology.

Clinical Trials with Interleukin-2. The Rome Experience

F. Calabresi, E. Ruggeri, 1992 .

Adoptive immunotherapy with high-dose interleukin-2: kinetics of circulating progenitors correlate with interleukin-6, granulocyte colony-stimulating factor level.

C. Peschle, U. Testa, E. Tritarelli, 1991, Blood.

Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.

J. Bonneterre, L. Mauriac, D. Campos, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer.

D. Amadori, M. Marangolo, V. Lorusso, 1993, European journal of cancer.

Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer.

F. Cognetti, P. Carlini, D. Giannarelli, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial.

R. Demicheli, G. Altavilla, V. Adamo, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Doxifluridine in advanced colorectal cancer

F. Calabresi, Marina Repetto, M. Repetto, 1991, Journal of surgical oncology. Supplement.

Interleukin 2 and LAK Cells

F. Calabresi, E. Ruggeri, 1990 .

Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study.

F. Cognetti, A. Lombardi, G. Atlante, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Delayed progression of bone metastases with bisphosphonate therapy: a randomised phase III trial with intravenous Aredia (pamidronate disodium) in breast cancer patients

L. Mauriac, P. Conte, J. Latreille, 1993 .

Adoptive Immunotherapy of Advanced Cancer with LAK Cells and Different Dosages of Interleukin-2:Analysis of Lymphocyte Subpopulations

C. Peschle, G. Mariani, U. Testa, 1990 .

Fluctuations of Plasma β2-Microglobulin, Soluble Interleukin 2 Receptor and Interferon-Gamma Concentrations after Adoptive Immunotherapy with High-Dose Interleukin 2 and Lymphokine-Activated Killer Cells

C. Peschle, U. Testa, P. Carlini, 1989 .

Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.

T. Delozier, P. Goss, L. Mauriac, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical experience with the combined use of recombinant interleukin‐2 (IL2) and interferon alfa‐2a (IFNα) in metastatic melanoma

J. Monson, R. Stahel, A. Eggermont, 1991, British journal of haematology.

Neoadjuvant m‐vac (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder

C. Sternberg, V. Pansadoro, A. Platanìa, 1993, Cancer.

345 A multicenter, randomized study of two schedules of paclitaxel (PTX) in patients with advanced breast cancer (ABC)

J. Bergh, K. Gelmon, R. Paridaens, 1995 .

Paclitaxel neurotoxicity: clinical and neurophysiological study of 23 patients

A. Pace, F. Calabresi, M. Nardi, 1997, The Italian Journal of Neurological Sciences.

Interleukin-2, Interferon-α and Interleukin-2 plus Interferon-α in Renal Cell Carcinoma. A Randomized Phase Ii Trial

F. Cognetti, F. Boccardo, A. Rubagotti, 1998, Tumori.

Paclitaxel as salvage therapy in advanced pretreated ovarian cancer: a phase II study.

F. Cognetti, G. Atlante, F. Calabresi, 1997, American journal of clinical oncology.

Recombinant tumor necrosis factor for superficial bladder tumors.

C. Sternberg, I. D'Agnano, G. Zupi, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term culture of human LAK cells

C. Peschle, U. Testa, G. Isacchi, 2004, Cytotechnology.

Antiemetic Activity of High‐Dose Metoclopramide Combined with Methylprednisolone Versus Metoclopramide Alone in Dacarbazine‐Treated Cancer Patients: A Randomized Double‐Blind Study of the Italian Oncology Group for Clinical Research

M. Tonato, F. Roila, E. Ballatori, 1989, American journal of clinical oncology.

Carboplatin and 5-fluorouracil in poor performance status patients with advanced urothelial cancer.

C. Sternberg, V. Pansadoro, P. De Carli, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Fluorouracil-alone versus high-dose folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial of the Italian Oncology Group for Clinical Research (GOIRC).

C. Boni, F. di Costanzo, F. Calabresi, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Etoposide prior to cis-diamminedichloroplatinum in combination chemotherapy: in vitro and in vivo studies.

G. Zupi, A. Sacchi, F. Calabresi, 1985, European journal of cancer & clinical oncology.

Multicenter phase II trial of the single agent fotemustine in patients with advanced malignant melanoma.

M. Aapro, L. Dirix, A. Ardizzoni, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen.

C. Boni, M. Tonato, G. Cocconi, 1992, The New England journal of medicine.

On a Case of Rare Chromosomal Aberration 1

F. Calabresi, A. Alfieri, G. Porto, 2014 .

On a case of rare chromosomal aberration.

F. Calabresi, L. Gedda, A. Alfieri, 1967, Acta geneticae medicae et gemellologiae.

High dose-intense chemotherapy alone or in combination with interleukin-2 for small cell lung cancer: a pilot study.

C. Peschle, U. Testa, D. Giannarelli, 1994, Cancer investigation.

Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.

D. Giannarelli, L. di Lauro, F. Calabresi, 1991, Seminars in oncology.

Comparative effects of cyclophosphamide and isophosphamide on Lewis lung carcinoma.

F. Calabresi, C. Greco, A. Corsi, 1978, British Journal of Cancer.

Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study.

A. Ceribelli, M. Crecco, F. Calabresi, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Final report of a phase II study of interleukin 2 and interferon alpha in patients with metastatic melanoma.

R. Stahel, A. Lindemann, G. Stoter, 1995, British Journal of Cancer.

High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter study.

F. Gherlinzoni, M. Vignetti, F. Mandelli, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A combination of ifosfamide and mitoxantrone as salvage therapy in patients with advanced ovarian cancer

G. Atlante, F. Calabresi, M. Nardi, 1996, Cancer Chemotherapy and Pharmacology.

Delayed progression of bone metastases with pamidronate therapy in breast cancer patients: a randomized, multicenter phase III trial.

L. Mauriac, P. Conte, J. Latreille, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Lonidamine as a potentiating agent of the FAC regimen in the treatment of advanced breast cancer. Results of a multicentric randomized clinical study

R. Stolfi, D. Giannarelli, E. Cortesi, 1994 .

Alizapride alone or alizapride-dexamethasone compared with metoclopramide-dexamethasone in patients at high risk of acute emesis after cisplatin. A randomized cross-over study.

F. Calabresi, M. Nardi, P. Marolla, 1991, Acta oncologica.

Cyclophosphamide and Iphosphamide against Lewis Lung Carcinoma: Evaluation of Toxic and Therapeutic Effects

F. Calabresi, C. Greco, Marco Caputo, 1979, Tumori.

Biological response modifiers.

T. Gamucci, F. Calabresi, 1995, Lung cancer.

Erythropoietin for the prevention of anaemia in neoplastic patients treated with cisplatin.

T. Gamucci, F. Calabresi, M. Thorel, 1993, European journal of cancer.

Different metastatic potential of in vitro and in vivo lines selected from Lewis lung carcinoma: correlation with response to different bleomycin schedulings.

G. Zupi, A. Sacchi, F. Calabresi, 1981, Invasion & metastasis.

Oral doxifluridine in elderly patients with metastatic colorectal cancer: a multicenter phase II study.

A. Ceribelli, S. Ricci, A. Falcone, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II studies of 4'-iodo-4'-deoxydoxorubicin in advanced non-small cell lung, colon and breast cancers.

F. Cavalli, C. Sessa, S. Kaye, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Weekly gemcitabine in advanced or metastatic solid tumors

A. Ceribelli, F. Calabresi, C. F. Pollera, 2004, Investigational New Drugs.

Sequential administration of dacarbazine and fotemustine in disseminated melanoma

S Aamdal, SM Lee, JA Radford, 1991 .

A case of familial chromosomal aberration with G group mosaic.

F. Calabresi, L. Gedda, A. Alfieri, 1967, Acta geneticae medicae et gemellologiae.

Phase II study with topotecan in colorectal cancer

J. Wanders, J. Verweij, S. Kaye, 1993 .